Drugmaker Astellas Has Claims For DOJ Settlement Coverage
Pharmaceutical company Astellas' settlement with the U.S. Department of Justice for more than $102 million over its alleged Medicare fraud scheme involving medication for castration-resistant prostate cancer may be covered by...To view the full article, register now.
Already a subscriber? Click here to view full article